Seres Therapeutics Inc Capital Reinvestment Ratio
Seres Therapeutics Inc capital reinvestment ratio. Seres Therapeutics Inc (MCRB) has a Capital Reinvestment Ratio of 0.00x as of September 2025, meaning it reinvests 0% of its operating cash flow ($2.21 Million) in capital expenditures ($8.00K). Check MCRB cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Seres Therapeutics Inc (2016–2025)
Capital reinvestment ratio of Seres Therapeutics Inc from 2016 to 2025. This chart tracks Seres Therapeutics Inc's Capital Reinvestment Ratio across 3 annual periods. Also explore Seres Therapeutics Inc (MCRB) net asset momentum to track the company's year-over-year net asset growth rate.
Seres Therapeutics Inc Capital Reinvestment Ratio by Year (2016–2025)
Seres Therapeutics Inc capital reinvestment ratio by year from 2016 to 2025. For the full cash flow conversion analysis, see Seres Therapeutics Inc cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.23x | $1.12 Million | $252.00K | ▼ -84.2% |
| 2021 | 1.43x | $6.69 Million | $9.57 Million | ▲ +192.3% |
| 2016 | 0.49x | $43.92 Million | $21.49 Million | — |